Catalyst Wire Dossier Catalyst Wire Dossier
EMA approval · 2021-05-21

First gene therapy to treat children with rare inherited neurological disease

View source ↗

Summary

EMA announces the first gene therapy approved to treat a rare inherited neurological disease in children, marking a milestone in pediatric genetic treatment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications